The effect of chromosomal translocations in acute leukemias: The LMO2 paradigm in transcription and development

Cancer Research

Volumn 59, Issue 7 SUPPL., 1999, Pages

  Rabbitts, Terence H ^a   Bucher, Katharina ^a   Chung, Grace ^a   Grutz, Gerald ^a   Warren, Alan ^a   Yamada, Yoshi ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; TRANSCRIPTION FACTOR;

ANIMAL CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CHROMOSOME TRANSLOCATION; CONFERENCE PAPER; DNA BINDING; GENE ACTIVATION; GENE MUTATION; GENETIC TRANSCRIPTION; HEMATOPOIESIS; HUMAN; HUMAN CELL; MOUSE; MULTIGENE FAMILY; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; T CELL LEUKEMIA;

EID: 0033118161     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (48)

1. Rabbitts, T. H. Chromosomal translocations in human cancer. Nature (Lond.), 372: 143-149, 1994
2. Adams, J. M., and Cory, S. Transgenic models of tumor development. Science (Washington DC), 254: 1161-1167, 1991.
3. Corral, J., Lavenir, I., Impey, H., Warren, A. J., Forster, A., Larson, T. A., Bell, S., McKenzie, A. N. J., King, G., and Rabbitts, T. H. An M11-Af9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes. Cell, 85: 853-861, 1996.
4. Rabbitts, T. H., Hamlyn, P. H., and Baer, R. Altered nucleotide sequences of a translocated c-myc gene in Burkitt lymphoma. Nature (Lond.), 306: 760-765, 1983.
5. Rabbitts, T. H., Forster, A., Hamlyn, P. H., and Baer, R. Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphoma. Nature (Lond.), 309: 592-597, 1984.
6. Showe, L. C., Ballantine, M., Nishikura, K., Erikson, J., Kaji, H., and Croce, C. M. Cloning and sequencing of a c-myc oncogene in a Burkitt's lymphoma cell line that is translocated to a germ line a switch region. Mol. Cell. Biol., 5: 501-509, 1985.
7. Murphy, W., Sarid, J., Taub, R., Vasicek, T., Battey, J., Lenoir, G., and Leder, P. Translocated human c-myc oncogene is altered in a conserved coding sequence. Proc. Natl. Acad. Sci. USA, 83: 2939-2943, 1986.
8. Cesarman, E., Dalla-Favera, R., Bentley, D., and Groudine, M. Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma. Science (Washington DC), 238: 1272-1275, 1987.
9. Morse, B., South, V. J., Rothberg, P. G., and Astrin, S. M. Somatic mutation and transcriptional deregulation of myc in endemic Burkitt's lymphoma disease: heptamer-nonamer recognition mistakes? Mol. Cell. Biol., 9: 74-82, 1989.
10. Bhatia, K., Huppi, K., Spangler, G., Siwarski, D., Iyer, R., and Magrath, I. Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas. Nat. Genet., 5: 56-61, 1993.
11. Yano, T., Sander, C. A., Clark, H. M., Dolezal, M. V., Jaffe, E. S., and Raffeld, M. Clustered mutations in the second exon of the MYC gene in sporadic Burkitt's lymphoma. Oncogene. 8: 2741-2748, 1993.
12. Boehm, T., Baer, R., Lavenir, I., Forster, A., Waters, J. J., Nacheva, E., and Rabhitts, T. H. The mechanism of chromosomal translocation t(11;14) involving the T-cell receptor Cδ locus on human chromosome 14q11 and a transcribed region of chromosome 11p15. EMBO J., 7: 385-394, 1988.
13. McGuire, E. A., Hockett, R. D., Pollock, K. M., Banholdi, M. F., O'Brien, S. J., and Korsmeyer, S. J. The t(11;14)(p15;q11) in a T-cell acute lymphoblastic leukemia cell line activates multiple transcripts, including Ttg-1, a gene encoding a potential zinc finger protein. Mol. Cell. Biol., 9: 2124-2132, 1989.
14. Boehm, T., Greenberg, J. M., Buluwela, L., Lavenir, I., Forster, A., and Rabbitts, T. H. An unusual structure of a putative T cell oncogene which allows production of similar proteins from distinct mRNAs. EMBO J., 9: 857-868, 1990.
15. Boehm, T., Foroni, L., Kennedy, M., and Rabbitts, T. H. The rhombotin gene belongs to a class of transcriptional regulators with a potential novel protein dimerisation motif. Oncogene, 5: 1103-1105, 1990.
16. Boehm, T., Foroni, L., Kaneko, Y., Perutz, M. P., and Rabbitts, T. H. The rhombotin family of cysteine-rich LIM-domain oncogenes: Distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. Proc. Natl. Acad. Sci. USA, 88: 4367-4371, 1991.
17. Foroni, L., Boehm, T., White, L., Forster, A., Sherrington, P., Liao, X. B., Brannan, C. I., Jenkins, N. A., Copeland, N. G., and Rabbitts, T. H. The rhombotin gene family encode related LIM-domain proteins whose differing expression suggests multiple roles in mouse development. J. Mol. Biol., 226: 747-761, 1992.
18. Royer-Pokora, B., Loos, U., and Ludwig, W.-D. TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11). Oncogene, 6: 1887-1893, 1991.
19. Sanchez-Garcia, I., Kaneko, Y., Gonzalez-Sarmiento, R., Campbell, K., White, L., Boehm, T., and Rabbitts, T. H. A study of chromosome 11p13 translocations involving TCRβ and TCRδ in human T cell leukaemia. Oncogene, 6: 577-582, 1991.
20. Sanchez-Garcia, I., and Rabbitts, T. H. The LIM domain: a new structural motif in zinc-finger-like proteins. Trends Genet., 10: 315-320, 1994.
21. Perez-Alvarado, G. C., Miles, C., Michelsen, J. W., Louis, H. A., Winge, D. R., Beckerle, M. C., and Summers, M. F. Structure of the carboxy-terminal LIM domain from the cysteine rich protein CRP. Nat. Struct. Biol., 1: 388-398, 1994.
22. Warren, A. J., Colledge, W. H., Carlton, M. B. L., Evans, M. J., Smith, A. J. H., and Rabbitts, T. H. The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell, 78: 45-58, 1994.
23. Yamada, Y., Warren, A. W., Dobson, C., Forster, A., Pannell, R., and Rabbitts, T. H. The T cell leukaemia LIM protein Lmo2 is necessary for adult mouse haematopoiesis. Proc. Natl. Acad. Sci. USA, 95: 3890-3895, 1998.
24. Robb, L., Lyons, I., Li, R., Hartley, L., Kontgen, F., Harvey, R. P., Metcalf, D., and Begley, C. G. Absence of yolk sac hematopoiesis from mice with a targeted disrup-tion of the scl gene. Proc. Natl. Acad. Sci. USA, 92: 7075-7079, 1995.
25. Shivdasani, R. A., Mayer, E., and Orkin, S. H. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature (Lond.), 373: 432-434, 1995.
26. Robb, L., Elwood, N. J., Elefanty, A. G., Kontgen, F., Li, R., Barnet, L. D., and Begley, C. G. The scl gene product is required for the generation of all hematopoietic lineages in the adult mouse. EMBO J., 15: 4123-4129, 1996.
27. Porcher, C., Swat, W., Rockwell, K., Fujiwara, Y., Alt, F. W., and Orkin, S. H. The T cell leukemia oncoprotein SCl/tal-1 is essential for development of all hematopoietic lineages. Cell, 86: 47-57, 1996.
28. Begley, C. G., Aplan, P. D., Davey, M. P., Nakahara, K., Tchorz, K., Kurtzberg, J., Hershfield, M. S., Haynes, B. F., Cohen, D. I., Waldmann, T. A., and Kirsch, I. R. Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor 8-chain diversity region and results in a previously unreported fusion transcript. Proc. Natl. Acad. Sci. USA, 86: 2031-2035, 1989.
29. Begley, C. G., Aplan, P. D., Denning, S. M., Haynes, B. F., Waldmann, T. A., and Kirsch, I. R. The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. Proc. Natl. Acad. Sci. USA, 86: 10128-10132, 1989.
30. Bernard, O., Guglielmi, P., Jonveaux, P., Cherif, D., Gisselbrecht, S., Mauchauffe, M., Berger, R., Larson, C-J., and Mathieu-Mahul, D. Two distinct mechanisms for the SCL gene activation in the t(1;14) translocation of T-cell leukemias. Genes Chromosomes Cancer, 1: 194-210, 1989.
31. Finger, L. R., Kagan, J., Christopher, G., Kurtzberg, J., Hershfield, M. S., Nowell, P. C., and Croce, C. M. Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. Proc. Natl. Acad. Sci. USA, 86: 5039-5043, 1989.
32. Chen, Q., Cheng, J.-T., Tsai, L-H., Schneider, N., Buchanan, G., Carroll, A., Crist, W., Ozanne, B., Siciliano, M. J., and Baer, R. The tal gene undergoes chromosome translocation in T cell leukaemia and potentially encodes a helix-loop-heilx protein. EMBO J., 9: 415-424, 1990.
33. Chen, Q., Yang, C. Y-C., Tsan, J., Xia, Y., Ragab, A. H., Peiper, S. C., Carroll, A., and Baer, R. Coding sequences of the tal-1 gene are disrupted by the chromosome translocation in human T cell leukaemia. J. Exp. Med., 172: 1403-1408, 1990.
34. Hsu, H-L., Cheng, J-T., Chen, Q., and Baer, R. Enhancer-binding activity of the tal-1 oncoprotein in association with the E47/E12 helix-loop-helix proteins. Mol. Cell. Biol., 17: 3037-3042, 1991.
35. Hsu, H.-L., Huang, L., Tsan, J. T., Funk, W., Wright, W. E., Hu, J-S., Kingston, R. E., and Baer, R. Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins. Mol. Cell. Biol., 14: 1256-1265, 1994.
36. Valge-Archer, V. E., Osada, H., Warren, A. J., Forster, A., Li, J., Baer, R., and Rabbitts, T. H. The LIM protein RBTN2 and the bHLH protein TAL1 are present in a complex in erythroid cells. Proc Natl. Acad. Sci. USA, 91: 8617-8621, 1994.
37. Wadman, I., Li, J., Bash, R. O., Forster, A., Osada, H., Rabbitts, T. H., and Baer, R. Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukaemia. EMBO J., 13: 4831-4839, 1994.
38. Schmeichel, K. L., and Beckerle, M. C. The LIM domain is a modular protein-binding interface. Cell, 79: 211-219, 1994.
39. Osada, H., Grutz, G., Axelson, H., Forster, A., and Rabbitts, T. H. Association of erythroid transcription factors: complexes involving the LIM protein RBTN2 and the zinc-finger protein GATA1. Proc. Natl. Acad. Sci. USA, 92: 9585-9589, 1995.
40. Wadman, I. A., Osada, H., Grutz, G. G., Agulnick, A. D., Westphal, H., Forster, A., and Rabbitts, T. H. The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO J., 16: 3145-3157, 1997.
41. Valge-Archer, V., Forster, A., and Rabbitts, T. H. The LMO1 and LDB1 proteins interact in human T-cell acute leukemia with the chromosomal translocation t(11;14)(p15;q11). Oncogene, 17: 3199-3202, 1998.
42. Pevny, L., Simon, M. C., Robertson, E., Klein, W. H., Tsai, S-F., D'Agati, V., Orkin, S. H., and Costantini, F. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature (Lond.), 349: 257-260, 1991.
43. Robb, L., Rasko, J. E. J., Bath, M. L., Strasser, A., and Begley, C. G. scl, a gene frequently activated in human T cell leukaemia, does not induce lymphomas in transgenic mice. Oncogene, 10: 205-209, 1995.
44. Fisch, P., Boehm, T., Lavenir, J., Larson, T., Arno, J., Forster, A., and Rabbitts, T. H. T-cell acute lymphoblastic lymphoma induced in transgenic mice by the RBTN1 and RBTN2 LIM-domain genes. Oncogene, 7: 2389-2397, 1992.
45. Larson, R. C., Osada, H., Larson, T. A., Lavenir, I., and Rabbitts, T. H. The oncogenic LIM protein Rbtn2 causes thymic developmental aberrations that precede malignancy in transgenic mice. Oncogene, 11: 853-862, 1995.
46. Neale, G. A., Rehg, J. E., and Goorha, R. M. Ectopic expression of rhombotin-2 causes selective expansion of the thymus and T-cell tumours in transgenic mice. Blood, 86: 3060-3071, 1995.
47. Larson, R. C., Lavenir, I., Larson, T. A., Baer, R., Warren, A. J., Wadman, I., Nottage, K., and Rabbitts, T. H. Protein dimerisation between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice. EMBO J., 15: 1021-1027, 1996.
48. Grutz, G., Bucher, K., Lavenir, I., Larson, R., Larson, T., and Rabbitts, T. H. The oncogenic T cell LIM-prolein Lmo2 forms part of a DNA-binding complex specifically in immature T cells. EMBO J., 17: 4594-4605, 1998.